Cholesterol Is a Gut Story
Most conversations about cholesterol focus on dietary fat, genetics, and statin medications. But there is a missing chapter: your gut microbiome actively regulates cholesterol metabolism through multiple pathways. From bile acid recycling to direct cholesterol conversion, gut bacteria are silent partners in determining your lipid levels and cardiovascular risk.
This is not fringe science. A 2023 study in Cell identified specific gut bacterial species that could account for up to 6% of variation in blood cholesterol levels — comparable to the effect of some dietary interventions.
How Gut Bacteria Affect Cholesterol
Bile Acid Metabolism
The primary mechanism is through bile acid metabolism. Cholesterol is the precursor to bile acids: the liver converts cholesterol into bile acids, which are secreted into the intestine to aid fat digestion. Normally, about 95% of bile acids are reabsorbed in the terminal ileum and recycled. Gut bacteria influence this process by converting primary bile acids into secondary forms, which are less efficiently reabsorbed. When more bile acids escape into the colon rather than being recycled, the liver must use more cholesterol to synthesise replacement bile acids, effectively pulling cholesterol out of circulation.
Direct Cholesterol Metabolism
Certain gut bacteria can directly metabolise cholesterol. Species including Eubacterium coprostanoligenes convert cholesterol to coprostanol, a form that is poorly absorbed and is excreted in the stool. Individuals who harbour higher populations of cholesterol-reducing bacteria tend to have lower serum cholesterol levels. A 2022 study in Cell Host and Microbe identified bacterial enzymes called IsmA (intestinal sterol metabolism A) that are responsible for this conversion and found them in a surprisingly large proportion of human gut microbiomes.
SCFA-Mediated Effects
Short-chain fatty acids produced by bacterial fermentation of dietary fibre have indirect effects on cholesterol metabolism. Propionate inhibits HMG-CoA reductase — the same enzyme targeted by statin drugs — in the liver, reducing cholesterol synthesis. Butyrate activates AMPK, which broadly improves lipid metabolism. Acetate, however, can serve as a substrate for hepatic lipogenesis, which is why the overall SCFA profile matters more than any single acid.
TMAO and Cardiovascular Risk
Certain gut bacteria convert dietary choline, carnitine, and betaine into trimethylamine (TMA), which the liver oxidises to trimethylamine N-oxide (TMAO). Elevated TMAO is independently associated with increased cardiovascular disease risk, atherosclerotic plaque instability, and adverse cardiac events. The composition of your gut bacteria determines how much TMAO is produced from a given diet, which is why two people eating identical diets can have vastly different cardiovascular risk profiles.
Microbiome-Based Strategies for Cholesterol Management
Increase Dietary Fibre
Soluble fibre (oats, barley, legumes, psyllium) binds bile acids in the intestine, increasing their faecal excretion and forcing the liver to use more cholesterol for replacement synthesis. The fibre also feeds SCFA-producing bacteria, increasing propionate production. A meta-analysis of 67 trials found that each additional 10 grams of soluble fibre daily reduces LDL cholesterol by approximately 5%.
Eat Fermented Foods
Fermented dairy products, particularly yoghurt and kefir containing Lactobacillus species, have been associated with modest but consistent cholesterol reductions in clinical trials. The mechanism involves bacterial bile salt hydrolase activity, which deconjugates bile acids and reduces their reabsorption.
Increase Plant Sterol and Stanol Intake
Plant sterols compete with cholesterol for intestinal absorption. Foods fortified with sterols or stanols (2g daily) can reduce LDL cholesterol by 5-15%. Their efficacy is influenced by gut microbiome composition, which modulates sterol metabolism.
Reduce TMAO-Promoting Foods
If TMAO is elevated, reducing intake of red meat, full-fat dairy, and egg yolks can help. But the more effective long-term strategy is to shift the microbiome away from TMA-producing species through increased fibre diversity and fermented food consumption.
Cholesterol management is not just about what you eat or which medications you take. It is also about the bacteria that process your food. GutIQ can help you understand how your digestive health may be influencing metabolic risk factors, including cholesterol and cardiovascular health.